Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2011 / Article

Original Article | Open Access

Volume 2011 |Article ID 474026 | https://doi.org/10.1093/ecam/nep039

Esra Küpeli Akkol, Ufuk Koca, Ipek Pesin, Demet Yilmazer, "Evaluation of the Wound Healing Potential of Achillea biebersteinii Afan. (Asteraceae) by In Vivo Excision and Incision Models", Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 474026, 7 pages, 2011. https://doi.org/10.1093/ecam/nep039

Evaluation of the Wound Healing Potential of Achillea biebersteinii Afan. (Asteraceae) by In Vivo Excision and Incision Models

Received10 Dec 2008
Accepted07 Apr 2009
Published16 Jun 2011


Achillea species are widely used for diarrhea, abdominal pain, stomachache and healing of wounds in folk medicine. To evaluate the wound healing activity of the plant, extracts were prepared with different solvents; hexane, chloroform, ethyl acetate and methanol, respectively from the roots of Achillea biebersteinii. Linear incision by using tensiometer and circular excision wound models were employed on mice and rats. The wound healing effect was comparatively evaluated with the standard skin ointment Madecassol. The n-hexane extract treated groups of animals showed 84.2% contraction, which was close to contraction value of the reference drug Madecassol (100%). On the other hand the same extract on incision wound model demonstrated a significant increase (40.1%) in wound tensile strength as compared to other groups. The results of histoptological examination supported the outcome of linear incision and circular excision wound models as well. The experimental data demonstrated that A. biebersteinii displayed remarkable wound healing activity.

1. Introduction

The genus Achillea (Asteraceae), named after the mythological Greek warrior Achilles, who used Achillea species for healing wounded-soldiers during the Trojan War [1]. The genus Achillea comprises of ~85 species, most of which are endemic to Europe and the Middle East. Turkish flora possesses 42 Achillea species and 23 of them are endemic [2]. These species have some interesting properties and are used in cosmetics, fragrances and agriculture, for example, plant protection [3]. Some Achillea species have been known to be ethnopharmacologically used in folk remedies for various purposes such as hemorrhoid and wound healing [4]. Herbal teas prepared from some Achillea species are very often used in folk medicine as diuretic, for abdominal pain, against diarrhea, flatulence and emmenagog, moreover for wound healing purposses, in Turkey [57].

Achillea biebersteinii is locally named Sarıçiçek in Turkish, and other species widely used as a folk remedy to treat abdominal pain, wounds and stomachache as well [8, 9]. A. biebersteinii Afan. [Asteraceae, Section: Filipendulinae (D.C.) Boiss] (syn. A. micrantha) is a perennial herb, villose, stems erect, simple or branched from the base; 30–60 cm high; leaves up to 10 cm, oblong-lanceolate in outline, pinnatisect into numerous narrow segments, segments divided into minute linear-lanceolate mucronate lobes; the heads are radiate, in large dense compound corymbs; involucre 4-5 mm, oblong-ovoid; flowering period, April-May.

Several biological activity studies have been performed on various Achillea species, including antibacterial, antioxidant, anti-inflammatory and antispasmodic activities [1013].

The aim of the present study was to investigate the in vivo wound healing activity of A. biebersteinii in order to elucidate traditional use of this plant from the scientific point of view. The hexane, chloroform, ethyl acetate and methanolic extracts prepared from the aerial parts of the mentioned plant were tested in mice and rats for wound healing activity using in vivo circular excision and linear incision wound models.

2. Materials and Methods

2.1. Plant Material

Achillea biebersteinii Afan. aerial parts were collected from Beynam forest, Ankara, Turkey, in May 2007 and was identified by Prof. Dr M. Vural from the Department of Botany, Faculty of Art and Science, Gazi University. A voucher specimen was deposited in the Herbarium of Faculty of Pharmacy, Gazi University (GUE-2602).

2.2. Extraction

Following dissection of the aerial parts of A. biebersteinii Afan., they were shade dried. Each 30 g aerial parts was submitted to successive solvent extractions seperatelly with n-hexane, chloroform, ethyl acetate and methanol at room temperature for a day (500 ml each solvent). This was repeated in two trials. After filtration, the extracts were evaporated at 40°C (Buchi, Switzerland) to dryness in vacuo. Yields of each extracts were 7.9% for n-hexane, 4.8% for diethyl ether, 1.3% for ethyl acetate and 15.3% for methanol.

2.3. GC-MS Analysis of the n-Hexane Fraction

Chromatographic analysis was carried out on Agilent 6890N Network GC system combined with Agilent 5973 Network Mass Selective Detector (GC-MS). The capillary column used was an HP 5 MS Column (30 m × 0.25 mm × 0.25  m). Helium was used as carrier gas at a flow rate of 1 ml/min with 1  l injection volume. Samples were analyzed with the column held initially 60°C for 1 min after injection with 1 min hold time, then increased to 180°C with 3°C/min heating ramp and kept at 180°C for 20 min. The injection was performed in splitless mode. Detector and injector temperatures were 280°C and 250°C, respectively. Run time was 60 min. MS scan range was (m/z): 35–500 atomic mass units (AMU) under electron impact (EI) ionization (70 eV).

2.4. Animals

Male, Sprague-Dawley rats (160–180 g body weight) and Swiss albino mice (20–25 g body weight) were purchased from the animal breeding laboratories of Refik Saydam Central Institute of Health (Ankara, Turkey).

The animals left for 3 days at room conditions for acclimatization. They were maintained on standard pellet diet and water ad libitum throughout the experiment. A minimum of six animals were used in each group, otherwise described in procedure. The study was permitted by the Institutional Animal Ethics Committee (Gazi University Ethical Council Project Number: G.U.ET-08.037) and was performed according to the international rules considering the animal experiments and biodiversity right.

2.5. Wound Healing Activity

Incision and excision wound models were used to evaluate the wound healing activity. For the in vivo wound models, samples were prepared in the ointment consists of propylene glycol : liquid paraffin (6 : 1) and applied topically onto the test animals Extracts were prepared as 1% in the ointment, and 0.5 mg of it applied on the wound sides immediately after wound was created artificially.

The vehicle group of animals was treated with the ointment only. The negative control group of animals was not treated with a material. Commercial Madecassol, 0.5 g (Bayer) was applied as a reference drug.

2.6. Linear Incision Wound Model

All the animals were anaesthetized with 0.15 cc Ketalar and the back hair of the rats were shaved by using a shaving machine. Five centimeters long, two linear-paravertebral incisions were made with a sterile blade through the full thickness of the skin at the distance of 1.5 cm from the midline of each side of the vertebral column [14]. The wounds were closed with three surgical interrupted sutures of 1 cm apart. The animals were divided into four groups. The extracts, the reference material (Madecassol) and the vehicle were topically applied once in a day through 9 days. The fourth group, negative control group of animals, was not treated with a material. All the sutures were removed on the 9th post wound day. On day 10 all the animals were killed with ether anesthesia. One linear-paravertebral incised skin was measured using tensiometer (Zwick/Roell Z0.5, Germany) for its tensile strength, the other incised skin was sent for histopathological examination [15, 16].

2.7. Excision Wound Model

This model was used to monitor wound contraction and wound closure time. Each group of animals (six-animal each) was anaesthetized by 0.01 cc Ketalar. The back hairs of the mice were depilated by shaving. The circular wound was created on the dorsal interscapular region of each animal by excising the skin with a 5 mm biopsy punch; wounds were left open [17]. The extracts, the reference material (Madecassol Bayer) and the vehicle ointment were administered once a day till the wound was completely healed. The progressive changes in wound area were monitored by a camera (Fuji, S20 Pro, Japan) every other day. Later on, wound area evaluated by using AutoCAD program. Wound contraction was calculated as percentage of the reduction in wounded area. A specimen sample of tissue was isolated from the healed skin of each group of mice for the histopathological examination [18].

2.8. Histological Study

Sample tissues were fixed in 10% formalin and were embedded in paraffin wax. Serial sections (5  m thickness) of paraffin embedded tissues were cut. The tissues were stained by haematoxylin and eosin, which were examined by light microscope (Olympus BX51). Ulceration, necrosis and epithelisation were evaluated in the skin tissues. Also congestion, edema, PNL, mononuclear cells, fibroblasts and vascularisation were qualitatively evaluated as −, +, ++ and +++.

2.9. Statistical Analysis of the Data

The data on percentage wound healing was statistically analyzed using one-way analysis of variance (ANOVA). The values of P ≤  .001 were considered statistically significant.

Mann-Whitney U, Kruskal-Wallis and chi-squared tests were used for the statistical analysis of the histopathological data.

3. Results

3.1. Excision and Incision Wound Models

In this study, an enquiry on wound healing activity of the n-hexane, chloroform, ethyl acetate and methanol extracts prepared from aerial parts of A. biebersteinii, which has been used in the treatment of wounds was carried out on mice and on rats by excision and linear incision wound models to verify the claimed traditional use of the plant on a scientific base. More to the point, histopathologic examination of the same extracts were also assessed.

The measurements of the progress of wound healing induced by the extracts, reference drug, negative control and vehicle groups in the excision wound model are shown in Figure 1. The n-hexane extract treated groups of animals showed 61.7% (P <  .01) contraction on the wounds on day eight. This extract demonstrated 84.2% (P <  .001) contraction on day twelfth, which was close to contraction value of the reference drug Madecassol® (100%). On the given days, other extracts showed no significant results.

The results of the measurements of tensile strength are shown in Figure 2. Tensile strength of the animals treated with n-hexane extract demonstrated the highest value (40.1%, P <  .001) on day 10. Topical application of the n-hexane extract on incision wound model demonstrated a significant increase in wound tensile strength as compared to other groups.

3.2. Histological Study

Histopatological examinations of the negative control exhibited wide area of ulceration containing fibrinous exudate and inflammatory cells, mild degree inflammation and mixed type inflammatory cells in dermis, slightly increased vascularization with congestion, which alltogether show that the healing was not completed on the wounded area (Figure 3). When the n-hexane extract treated group was histopathologically analyzed, establishment of collagen fibers, fibroblasts and mature hair follicles were obviously seen on the representing picture (Figure 4). Moreover, no scar tissue on the dermis in n-hexane treated group exhibits that the healing was almost completed. In a similar way, group treated with Madecassol showed mature epidermis with keratinization and mature hair follicles, fibroblasts in dermis that are the proof of completion of healing (Figure 5). Histological observation suggested that the phytochemical content of the n-hexan extract might be responsible for collagen formation at the proliferative state, which is contributed by increased fibroblats content (Figure 6).

4. Discussion

Overall the histopathological examinations showed that healing process of the wounded tissue in n-hexane treated group was comparably close to the reference drug treated group, whereas no healing was observed in negative control group (untreated). Granulation tissue primarily contains fibroblasts, collagen fibres, very less edema and newly generated blood vessels, which were also observed in n-hexane extract treated group of animals. This histopathological observation provided additional evidence for the experimental wound healing studies based on the contraction value of wound areas and the measurement of tensile strength (Figures 35).

In the present study, the n-hexane extract of A. biebersteinii aerial parts was found to be remarkably active on in vivo wound models, whereas the other extracts were not as active as the n-hexane extract. This prompted us to analyze and identify chemical composition of the n-hexane extract directly by capillary GC-MS. Analysis of the n-hexane fraction revealed that the major compounds were determined as sesquiterpenoid β-Eudesmol, piperitone, camphor, borneol, α-terpinene, 1,8-cineole, although their amounts were 19.1%, 9.2%, 4.2%, 3.3%, 2.9% and 2.5% respectively representing 100% of the extract (Table 1).

Components identifiedRetention times (R t, min)Composition (%) n-hexane fr.

Bicyclo [2,2,1]heptane-2,5-dione16.8080.305
Decanoic acid21.6730.981
Caryophyllene oxide29.7193.123
Caryophylla-4(14), 8(15)-dien-5-beta-ol31.7371.162
Vulgarol B33.5650.506
Phthalic acid39.9822.590
Hexadecanoic acid43.6321.338
Oleic acid46.7970.536
Methyl linoleate52.3093.028


Achillea species have been so far reported to contain diterpenes, sesquiterpenes, flavonoids, lignans, essential oil and rarely triterpenes [1926]. For instance, A. vermicularis was shown to have guaianolide- and germacrene-type sesquiterpenes as well as flavonoids, whereas A. setacea was reported to contain sesquiterpenes, essential oils and flavonoids [20, 21, 27]. In addition to extracts, essential oils of the Achillea species were also analysed. The oil of A. pachycephala was found to contain 1,8-cineole and camphor as the major constituents, whereas 1,8-cineole and artemisia ketone were major in A. oxyodonta. On the other hand A. biebersteinii was rich in camphor and borneol followed by 1,8-cineole. It was stated that all the oils were rich in oxygenated monoterpenes [28]. Non-volatile components of A. biebersteinii afforded in addition to β-sitosterol, stigmasterol two sesquiterpene lactones, germacranolide [29]. Essential oil of A. millefolium consists of a number of monoterpenes such as α-pinene, β-pinene, 1,8-cineole, camphor and borneol in addition to some sesquiterpene lactones of germacrene-derivatives [25]. Major component in the essential oils of both A. setacea and A. teretifolia was elucidated to be 1,8-cineole [27] whereas α-pinene, 1,8-cineole and camphor as well as germacrene D and bisabolene as the major constituents of ten other Achillea species (A. biserrata, A. clypeotala, A. crithmifolia, A. filipendula, A. macrophylla, A. pannonica, A. pyrenaica, A. sibirica, A. taygetea and A. tenuifolia) [23].

Various biological activity studies were also completed on Achillea species. The antimicrobial and antioxidant activities of the essential oil and the methanolic extract of A. biebersteinii were studied in vitro by Baris et al. [30]. The essential oil showed antimicrobial activity against 8 bacteria sp., 14 fungi sp. and the C. albicans, whereas the methanolic extract remained inactive. GC-MS analysis of the essential oil resulted in the identification of 64 components representing 92.24% of the oil, piperitone, camphor and 1,8-cineole (eucalyptol) as being major constituents [30]. In another study, antimicrobial activity tests carried out with the fractions of the oil revealed that the major activity was observed in those contain 1,8-cineole and camphor, followed by borneol and piperitone [31].

When a wound occurs and is exposed to external environment, it is more prone to attack by microbes, which invade through the skin and delay the natural wound healing process. Reactive oxygen species (ROS), are vital part of healing and serve as cellular messengers that drive numerous aspects of molecular and cell biology. ROS can trigger the various beneficial pathways of wound healing, for example, at micromolar concentrations of hydrogen peroxide can promote vascular endothelial growth factor (VEGF) expression in keratinocytes [32, 33]. During the inflammation phase of healing neutrophils and macrophages are attracted into the injured tissue by various chemotactic factors. They locate, identify, phagocytize, kill and digest microorganisms and eliminate wound debris through their characteristic “respiratory burst” activity and phagocytosis [34]. At high concentrations, ROS can induce severe tissue damage and even lead to neoplastic transformation, which further impede the healing process by causing damage to cellular membranes, DNA, proteins and lipids as well [35]. Hence, if a compound or a plant extract having antioxidant potentials and antimicrobial activity additionally, it can be a good therapeutic agent for accelerating the wound-healing process.

Several preparations containing A. millefolium extract was quite successfully healed the wounds and scars. The liniment containing hiperisin oil and A. millefolium extract patented by Motogna accelerates the healing of wounds and gives esthetic scars. Since the liniment is applied as a spray it is easily applied and painless [36]. The activiy most probably comes from the synergistic effect of compounds present in the extract and also additive effect of hiperisin.

According to ethnopharmacological studies botanical remedies provide two advantages over single-compound drugs: primary active compounds in plants are synergized by secondary compounds and secondary compounds ease the side effects caused by primary active compounds. The course of searching an ethnopharmacologically active plant extract down to a single active principal may result in a defeat of biological activity for a number of reasons, for instance, a special compound might be unstable during extraction, fractionation or in the purified form, or, the fundamental basis for ethnopharmacology does not always exist in a single active compound but rather is a result of the interaction of more than one active compounds found in the extract [37]. Moreover, that single compound might potentiate the activity and that single compound become toxic compared to whole plant extract [38]. Thus, the likelihood that more than one compound present in a plant extract could contribute to a net pharmacological response of the extract.

5. Conclusion

According to results reported here n-hexane extract of Achillea biebersteinii was found to have better activity on the wound healing experimental models compared to the other extracts. Even though the analysis of the n-hexane extract revealed that the major compounds were determined as sesquiterpenoid β-Eudesmol, piperitone, additional compounds, such as camphor, borneol, α-terpinene and 1,8-cineole were also determined. This unveils that the extract was not dominated by a single compound, whereas the extract contains various effective compounds in different quantities. This may suggest that β-Eudesmol and piperitone solely could not be reason for the activity but mostly synergistic interaction with the rest of the ingredients might be promoting the wound healing activity. This study provides scientific evidence to the ethnomedicinal futures of A. biebersteinii.


Thanks are due to Scientific Research Project Foundation of Gazi University, Ankara, Turkey for providing a financial support (Project code no: 02/2007-04).


  1. G. Cheers, Botanica, Könemann, Köln, Germany, 1999.
  2. H. Duman and L. Achillea, in Flora of Turkey and the East Aegean Islands, A. Guner, N. Ozhatay, T. Ekim, and K. H. C. Baser, Eds., vol. 11, pp. 158–159, Edinburgh University Press, Edinburgh, UK, 2000.
  3. F. Senatore, F. Napolitano, N. A. Arnold, M. Bruno, and W. Herz, “Composition and antimicrobial activity of the essential oil of Achillea falcata L. (Asteraceae),” Flavour and Fragrance Journal, vol. 20, no. 3, pp. 291–294, 2005. View at: Publisher Site | Google Scholar
  4. T. Baytop, Therapy with Medicinal Plants in Turkey, Past and Present, Nobel Tıp Kitapevi, Istanbul, Turkey, 2nd edition, 1999.
  5. E. Yeşilada, G. Honda, E. Sezik, M. Tabata, K. Goto, and Y. Ikeshiro, “Traditional medicine in turkey IV. Folk medicine in the Mediterranean subdivision,” Journal of Ethnopharmacology, vol. 39, no. 1, pp. 31–38, 1993. View at: Google Scholar
  6. T. Fujita, E. Sezik, M. Tabata et al., “Traditional medicine in Turkey VII. Folk medicine in middle and west Black Sea regions,” Economic Botany, vol. 49, no. 4, pp. 406–422, 1995. View at: Google Scholar
  7. G. Honda, E. Yeşilada, M. Tabata et al., “Traditional medicine in Turkey VI. Folk medicine in West Anatolia: Afyon, Kutahya, Denizli, Mugla, Aydin provinces,” Journal of Ethnopharmacology, vol. 53, no. 2, pp. 75–87, 1996. View at: Publisher Site | Google Scholar
  8. T. Baytop, “Türkçe Bitki Adlari Sözlügü, A Dictionary of vernacular names of wild, publication of the Turkish Language Society,” Ankara, vol. 578, pp. 163–238, 1997. View at: Google Scholar
  9. E. Sezik, E. Yeşilada, G. Honda, Y. Takaishi, Y. Takeda, and T. Tanaka, “Traditional medicine in Turkey X. Folk medicine in Central Anatolia,” Journal of Ethnopharmacology, vol. 75, no. 2-3, pp. 95–115, 2001. View at: Publisher Site | Google Scholar
  10. F. Candan, M. Unlü, B. Tepe et al., “Antioxidant and antimicrobial activity of the essential oils and methanol extracts of Achillea millefolium susp. millefolium Afan. (Asteraceae),” The Journal of Ethnopharmacology, vol. 87, pp. 215–220, 2003. View at: Google Scholar
  11. M. Skocibusic, N. Bezic, V. Dunkic, and A. Radonic, “Antibacterial activity of Achillea clavennae essential oil against respiratory tract pathogens,” Fitoterapia, vol. 75, no. 7-8, pp. 733–736, 2004. View at: Publisher Site | Google Scholar
  12. M. K. Al-Hindawi, I. H. S. Al-Deen, M. H. A. Nabi, and M. A. Ismail, “Anti-inflammatory activity of some Iraqi plants using intact rats,” Journal of Ethnopharmacology, vol. 26, no. 2, pp. 163–168, 1989. View at: Google Scholar
  13. C. Karamenderes and S. Apaydın, “Antispasmodic effect of Achillea nobilis L. subsp. sipylea (O. Schwarz) Bässler on the rat isolated duodenum,” Journal of Ethnopharmacology, vol. 84, no. 2-3, pp. 175–179, 2003. View at: Publisher Site | Google Scholar
  14. H. P. Ehrlich and T. K. Hunt, “The effects of cortisone and anabolic steroids on the tensile strength of healing wounds,” Annals of Surgery, vol. 57, p. 117, 1968. View at: Google Scholar
  15. S. Lodhi, R. S. Pawar, A. P. Jain, and A. K. Singhai, “Wound healing potential of Tephrosia purpurea (Linn.) Pers. in rats,” Journal of Ethnopharmacology, vol. 108, no. 2, pp. 204–210, 2006. View at: Publisher Site | Google Scholar
  16. L. Suguna, S. Singh, P. Sivakumar, P. Sampath, and G. Chandrakasan, “Influence of Terminalia chebula on dermal wound healing in rats,” Phytotherapy Research, vol. 16, no. 3, pp. 227–231, 2002. View at: Publisher Site | Google Scholar
  17. V. A. Tramontina, M. A. Machado, G. R. Nogueira Filho, S. H. Kim, M. R. Vizzioli, and S. Toledo, “Effect of bismuth subgallate (local hemostatic agent) on wound healing in rats. Histological and histometric findings,” Brazilian Dental Journal, vol. 13, no. 1, pp. 11–16, 2002. View at: Google Scholar
  18. F. Sadaf, R. Saleem, M. Ahmed, S. I. Ahmad, and Z. Navaid-ul, “Healing potential of cream containing extract of Sphaeranthus indicius on dermal wounds in Guinea pigs,” The Journal of Ethnopharmacology, vol. 107, pp. 161–163, 2006. View at: Google Scholar
  19. I. Aljancic, S. Macura, N. Juranic, S. Andjelkovic, N. Randjelkovic, and S. Milosavljevic, “Diterpenes from Achillea clyopetala,” Phytochemistry, vol. 43, pp. 169–171, 1996. View at: Google Scholar
  20. S. Öksüz, S. Gümüş, and K. Alpınar, “Sesquiterpenoids and flavonoids of Achillea species,” Biochemical Systematics and Ecology, vol. 19, no. 5, p. 439, 1991. View at: Google Scholar
  21. E. Marchart and B. Kopp, “Capillary electrophoretic separation and quantification of flavone-O- and C-glycosides in Achillea setacea W. et K,” Journal of Chromatography B, vol. 792, pp. 363–368, 2003. View at: Google Scholar
  22. A. A. Ahmed, A. A. Mahmoud, E. T. Ali et al., “Two highly oxygenated eudesmanes and 10 lignans from Achillea holosericea,” Phytochemistry, vol. 59, no. 8, pp. 851–856, 2002. View at: Publisher Site | Google Scholar
  23. M. Maffei, M. Mucciarelli, and S. Scannerini, “Essential oils from Achillea species of different geographic origin,” Biochemical Systematics and Ecology, vol. 22, no. 7, pp. 679–687, 1994. View at: Publisher Site | Google Scholar
  24. S. Kusmenoglu, K. H. C. Baser, T. Ozek, M. Harmandar, and X. Gokalp, “Constituents of the essential oil of Achillea biebersteinii Afan,” Journal of Essential Oil Research, vol. 7, no. 5, pp. 527–528, 1995. View at: Google Scholar
  25. D. Mockute and A. Judzentiene, “Variability of the essential oils composition of Achillea millefolium ssp. millefolium growing wild in Lithuania,” Biochemical Systematics and Ecology, vol. 31, no. 9, pp. 1033–1045, 2003. View at: Publisher Site | Google Scholar
  26. A. F. Barrero, R. E. A. Manzaneda, R. R. A. Manzaneda, S. Arseniyadis, and E. Guittet, “Achilleol B: a new tricyclic triterpene skeleton from Achillea odorata L,” Tetrahedron, vol. 46, no. 24, pp. 8161–8168, 1990. View at: Publisher Site | Google Scholar
  27. M. Ünlü, D. Daferera, E. Dönmez, M. Polissiou, B. Tepe, and A. Sökmen, “Compositions and the in vitro antimicrobial activities of the essential oils of Achillea setacea and Achillea teretifolia (Compositae),” Journal of Ethnopharmacology, vol. 83, no. 1-2, pp. 117–121, 2002. View at: Publisher Site | Google Scholar
  28. A. Esmaeili, F. Nematollahi, A. Rustaiyan, N. Moazami, S. Masoudi, and S. Bamasian, “Volatile constituents of Achillea pachycephala, A. oxyodonta and A. biebersteinii from Iran,” Flavour and Fragrance Journal, vol. 21, no. 2, pp. 253–256, 2006. View at: Publisher Site | Google Scholar
  29. K. O. Badahdah and H. S. El-Orfy, “Phytochemical constituents of Achillea biebersteinii,” Journal of Saudi Chemical Society, vol. 8, pp. 115–120, 2004. View at: Google Scholar
  30. Ö. Bariş, M. Güllüce, F. Şahin et al., “Biological activities of the essential oil and methanol extract of Achillea biebersteinii Afan. (Asteraceae),” Turkish Journal of Biology, vol. 30, no. 2, pp. 65–73, 2006. View at: Google Scholar
  31. A. Sökmen, M. Sökmen, D. Daferera et al., “The in vitro antioxidant and antimicrobial activities of the essential oil and methanol extracts of Achillea biebersteini Afan. (Asteraceae),” Phytotherapy Research, vol. 18, no. 6, pp. 451–456, 2004. View at: Publisher Site | Google Scholar
  32. S. Khanna, S. Roy, D. Bagchi, M. Bagchi, and C. K. Sen, “Upregulation of oxidant-induced VEGF expression in cultured keratinocytes by a grape seed proanthocyanidin extract,” Free Radical Biology and Medicine, vol. 31, no. 1, pp. 38–42, 2001. View at: Publisher Site | Google Scholar
  33. B. S. Nayak, S. Sandiford, and A. Maxwell, “Evaluation of the wound-healing activity of ethanolic extract of Morinda citrifolia L. leaf,” Evidence-Based Complementary and Alternative Medicine, vol. 6, no. 3, pp. 351–356, 2009. View at: Publisher Site | Google Scholar
  34. L. A. Clark and R. E. Moon, “Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections,” Respiratory Care Clinics of North America, vol. 5, no. 2, pp. 203–219, 1999. View at: Google Scholar
  35. A. Martin, “The use of antioxidants in healing,” Dermatologic Surgery, vol. 22, no. 2, pp. 156–160, 1996. View at: Google Scholar
  36. A. Motogna, “Liniment for treating serious burns,” (Combinatul de Industrie Locala), Rom. RUXXA3, RO 52874, 19711125, Appl. RO 68–58261, 1971. View at: Google Scholar
  37. S. Savelev, E. Okelloa, N. S. L. Perryb, R. M. Wilkinsa, and E. K. Perry, “Synergistic and antagonistic interactions of anticholinesterase terpenoids in essential oil,” Pharmacology Biochemistry and Behavior, vol. 75, pp. 661–668, 2003. View at: Google Scholar
  38. J. M. McPartland and P. L. Pruitt, “Side effects of pharmaceuticals not elicited by comparable herbal medicines: the case of tetrahydrocannabinol and marijuana,” Alternative Therapies in Health and Medicine, vol. 5, no. 4, pp. 57–62, 1999. View at: Google Scholar

Copyright © 2011 Esra Küpeli Akkol et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.